Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Nuhad Haddad"'
Autor:
Riva Fineman, Dvora Sahar, Nivin Moustafa-Hawash, Shimrit Ringelstein-Harlev, Nuhad Haddad, Dana Yehudai-Ofir, Jacob M. Rowe, Yuval Nov, Ofrat Beyar-Katz, Noa Lavi, Yishai Ofran, Tsila Zuckerman, Israel Henig
Publikováno v:
Leukemia & Lymphoma. 60:2449-2456
Autologous stem cell transplantation (ASCT), intensifying anti-leukemic effects without significant treatment-related mortality (TRM), is particularly appealing in AML with favorable genetic/molecular profile. This study retrospectively evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37d52a38b5d8ec750a0781443a23143
https://doi.org/10.1080/10428194.2019.1594214
https://doi.org/10.1080/10428194.2019.1594214
Publikováno v:
Harefuah. 158(3)
To determine the prevalence and incidence of HPA antigens and antibodies in the Israeli population and to evaluate the degree of awareness to F/NAIT in Israel.In fetal/neonatal alloimmune thrombocytopenia (F/NAIT) the fetus suffers from thrombocytope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00f12f08d34cd72e57fc74b25aa6e463
https://pubmed.ncbi.nlm.nih.gov/30916500
https://pubmed.ncbi.nlm.nih.gov/30916500
Autor:
Lilach Bonstein, Nuhad Haddad
Publikováno v:
Thrombosis research. 151
In fetal/neonatal alloimmune thrombocytopenia (FNAIT), platelets are destroyed by maternal antibodies directed against fetal/neonate antigens. Thrombocytopenia can be severe and lead to intracranial hemorrhage (ICH) in about 10% of cases. Although th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99dbf1208fb9f36cb2bdc22a17e0b22
https://pubmed.ncbi.nlm.nih.gov/28262226
https://pubmed.ncbi.nlm.nih.gov/28262226
Autor:
Avraham Frisch, Nuhad Haddad, Doaa Okasha, Riva Fineman, Yishai Ofran, Tsila Zuckerman, Israel Henig, Dina Rosenberg, Ronit Leiba, Yariv Carasso, Dana Yehudai-Ofir, Nurit Horesh
Publikováno v:
Blood. 134:2603-2603
Introduction: Mutations of the NPM1 gene (NPM1mut) are considered a favorable prognostic marker in acute myeloid leukemia (AML). Data from a prospective randomized trial have shown that in young AML patients with NPM1mut upfront allogeneic stem cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6b542ed5460d7e6fe670df1a1958365
https://doi.org/10.1182/blood-2019-126553
https://doi.org/10.1182/blood-2019-126553
Publikováno v:
Transfusion. 53:1019-1023
BACKGROUND: Administration of intensive chemotherapy used in the management of malignancies is accompanied with marrow suppression. Patients undergoing such treatments and especially those with acute leukemia need prolonged blood component support an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1af7315c3ad029a22c1b9dee244c0e8a
https://doi.org/10.1111/j.1537-2995.2012.03855.x
https://doi.org/10.1111/j.1537-2995.2012.03855.x
Autor:
Dvora Sahar, Yishai Ofran, Tsila Zuckerman, Yair Reisner, Edmond Sabo, Eldad J. Dann, Nuhad Haddad, Israel Gavish, Tamar Katz, Jacob M. Rowe, Riva Fineman, Tal Faibish, Irit Avivi, Eti Hertz
Publikováno v:
American Journal of Hematology. 87:875-879
The use of allogeneic stem cell transplantation (SCT) for chronic myeloid leukemia (CML) was almost abandoned in recent years for very effective targeted therapy with tyrosine kinase inhibitors (TKIs). However, approximately one third of patients sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93011a64d51f5bbc2dd83d3bc38619da
https://doi.org/10.1002/ajh.23263
https://doi.org/10.1002/ajh.23263
Autor:
Hanna Mandel, Ronit Elhasid, Amos Etzioni, Ivanka Sami, Sergey Postovsky, Dina Rubin, Osnat Gidoni, Ronit Leiba, Jacob M. Rowe, Ayelet Ben Barak, Nuhad Haddad, Yair Reisner, Tami Katz, Shimon Pollack, Irena Zaidman, Myriam Weyl Ben Arush, Dina Attias
Publikováno v:
Biology of Blood and Marrow Transplantation. 13(3):329-338
In an attempt to abrogate the deleterious effects of graft-versus-host disease (GVHD), allogeneic transplantation for nonmalignant diseases was performed using high-dose CD34-cell infusion, partial T cell depletion, and no posttransplantation GVHD pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1156b57178998e37ae51ae0213aaf2ee
Publikováno v:
Thrombosis Research. 116:109-114
In this retrospective study, the hemorrhagic and thrombotic events are reported at presentation and during induction in 34 consecutive acute promyelocytic leukemia (APL) patients treated in a single referral center. The most consistent hemostatic abn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f77a4df50979b009345af695806cc43d
https://doi.org/10.1016/j.thromres.2004.11.001
https://doi.org/10.1016/j.thromres.2004.11.001
Autor:
Nuhad Haddad, Jacob M. Rowe
Publikováno v:
Best Practice & Research Clinical Haematology. 17:377-386
Stem cell transplantation preceded by reduced-intensity conditioning (RIC) is based on the use of immunosuppressive agents as the sine qua non to ensure donor cell engraftment. It is a curative option for select patients suffering from haematological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2269cb27457dc70190ed31db62b7f80d
https://doi.org/10.1016/j.beha.2004.06.001
https://doi.org/10.1016/j.beha.2004.06.001
Publikováno v:
American Journal of Hematology. 75:6-11
Between March 1997 and January 2002, 18 consecutive patients (18-47 years) with hematological malignancies and previous proven invasive fungal infection underwent stem cell transplantation (SCT) (10 matched sibling allograft, 6 autograft, and 2 haplo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0ce60436eefa7c14178d328f302412
https://doi.org/10.1002/ajh.10447
https://doi.org/10.1002/ajh.10447